In the MSKCC/DFCI patient cohort consisting primary PCa (n = 1013 PCa cases) from the Prostate Oncogenenome Project dataset in cBioPortal databases [42], FCGR3A gene alterations were found in 3% of PCa cases, which was similar to PIP5K1A gene alterations accounted for 5% in this PCa cohort (Fig. S1). The gene discussed is PIP5K1A; the disease is posterior cortical atrophy.